LEXARIA BIOSCIENCE CORP. Common Stock, Value, Issued
LEXARIA BIOSCIENCE CORP. (LEXX) had Common Stock, Value, Issued of $24.79 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-07-13
- 2026-05-31: Common Stock, Value, Issued $24.79K.
- 2026-02-28: Common Stock, Value, Issued $24.89K.
- 2025-11-30: Common Stock, Value, Issued $22.23K.
- 2025-08-31: Common Stock, Value, Issued $19.56K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-05-31 | $24.79K 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $24.89K 10-Q · filed 2026-04-13 | |
| 2025-11-30 | $22.23K 10-Q · filed 2026-01-13 | |
| 2025-08-31 | $19.56K 10-Q · filed 2026-07-13 | |
| 2025-05-31 | $19.56K 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $17.56K 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $17.45K 10-Q · filed 2025-01-10 | |
| 2024-08-31 | $15.81K 10-K · filed 2025-11-28 | |
| 2024-05-31 | $15.81K 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $12.39K 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $10.31K 10-Q · filed 2024-01-12 | |
| 2023-08-31 | $8.09K 10-K · filed 2024-11-26 | |
| 2023-05-31 | $8.09K 10-Q · filed 2023-07-14 | |
| 2023-02-28 | $5.95K 10-Q · filed 2023-04-14 | |
| 2022-11-30 | $5.95K 10-Q/A · filed 2023-01-18 | |
| 2022-08-31 | $5.95K 10-K · filed 2023-11-20 | |
| 2022-05-31 | $5.95K 10-Q · filed 2022-07-14 | |
| 2022-02-28 | $5.95K 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $5.73K 10-Q · filed 2022-01-14 | |
| 2021-08-31 | $5.73K 10-K · filed 2022-11-28 | |
| 2021-05-31 | $5.10K 10-Q · filed 2021-07-15 | |
| 2021-02-28 | $5.10K 10-Q · filed 2021-04-14 | |
| 2020-11-30 | $3.00K 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $3.00K 10-K · filed 2021-11-29 | $90.04K 10-K · filed 2020-10-15 |
| 2020-05-31 | $89.59K 10-Q · filed 2020-06-29 | |
| 2020-02-29 | $80.72K 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $80.61K 10-Q · filed 2020-01-09 | |
| 2019-08-31 | $78.79K 10-K · filed 2020-10-15 | |
| 2019-05-31 | $78.44K 10-Q · filed 2019-07-08 | |
| 2019-02-28 | $78.00K 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $77.12K 10-Q · filed 2019-01-11 | |
| 2018-08-31 | $75.53K 10-K · filed 2019-11-14 | |
| 2018-05-31 | $72.40K 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $71.10K 10-Q · filed 2018-04-12 | |
| 2017-11-30 | $69.44K 10-Q · filed 2018-01-12 | |
| 2017-08-31 | $67.98K 10-K · filed 2018-11-14 | |
| 2017-05-31 | $66.55K 10-Q · filed 2017-07-14 | |
| 2017-02-28 | $56.29K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $55.01K 10-Q · filed 2017-01-13 | |
| 2016-08-31 | $51.29K 10-K · filed 2017-11-27 | |
| 2016-05-31 | $45.51K 10-Q · filed 2016-07-13 | |
| 2016-02-29 | $44.55K 10-Q · filed 2016-04-13 | |
| 2015-11-30 | $39.95K 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $43.84K 10-K · filed 2016-11-29 | $39.85K 10-K · filed 2015-11-27 |
| 2015-05-31 | $39.68K 10-Q · filed 2015-07-14 | |
| 2015-02-28 | $34.68K 10-Q · filed 2015-04-14 | |
| 2014-11-30 | $34.44K 10-Q · filed 2015-01-14 | |
| 2014-08-31 | $34.25K 10-K · filed 2015-11-27 | $34.25K 10-KT · filed 2014-12-09 |
| 2014-07-31 | $32.82K 10-Q · filed 2014-11-14 | |
| 2014-04-30 | $31.84K 10-Q · filed 2014-06-12 | |
| 2014-01-31 | $16.93K 10-Q · filed 2014-03-12 | |
| 2013-10-31 | $16.43K 10-KT · filed 2014-12-09 | |
| 2013-07-31 | $16.43K 10-Q · filed 2013-09-10 | |
| 2013-04-30 | $16.43K 10-Q · filed 2013-06-12 | |
| 2013-01-31 | $16.43K 10-Q · filed 2013-03-13 | |
| 2012-10-31 | $16.43K 10-K · filed 2014-01-24 | |
| 2012-07-31 | $16.43K 10-Q · filed 2012-09-12 | |
| 2012-04-30 | $16.43K 10-Q · filed 2012-06-07 | |
| 2012-01-31 | $16.43K 10-Q · filed 2012-03-13 | |
| 2011-10-31 | $16.43K 10-K · filed 2013-01-29 | |
| 2011-07-31 | $15.63K 10-Q · filed 2011-09-14 | |
| 2010-10-31 | $12.93K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |